Expression of DLC-1 in clear cell renal cell carcinoma: Prognostic significance for progression and metastasis

Urologia Internationalis

Volumn 82, Issue 4, 2009, Pages 380-387

  Zhang, Tao ^a   Zheng, Jingcun ^b   Liu, Chunfang ^a   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

^b Gongli Hospital   (China)

Author keywords

Clear cell renal cell carcinoma; Deleted in liver cancer 1; Matrix metalloproteinase 2; Metastasis

Indexed keywords

DELETED IN LIVER CANCER PROTEIN 1; GELATINASE A; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 67650296730     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218524     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
2. Motzer RJ, Bander NH, Nanus DM: Renalcell carcinoma. N Engl J Med 1996;335:865-875.
3. Yagoda A, Petrylak D, Thompson S: Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin North Am 1993;20: 303-321.
4. Yagoda A, Abi-Rached B, Petrylak D: Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol 1995; 22:42-60.
5. Zhou M, Rubin MA: Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Semin Urol Oncol 2001; 19: 80-87.
6. Durkin ME, Yuan BZ, Thorgeirsson SS, Popescu NC: Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7). Gene 2002; 288:119-127.
7. Wong CM, Lee JM, Ching YP, Jin DY, Ng IO: Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res 2003;63:7646-7651.
8. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, Novick A: TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80:992-993.
9. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655-663.
10. Stenzl A, deKernion JB: Pathology, biology and clinical staging of renal cell carcinoma. Semin Oncol 1989;16(suppl):3-15.
11. Froehner M, Hakenberg OW, Wirth MP: Molecular therapy in urologic oncology. Urol Int 2007;79:1-7.
12. Merseburger AS, Serth J, von der Heyde E, Kobierski A, Wegener U, Mengel M, Jonas U, Kuczyk M: Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features. Urol Int 2007;79:164-169.
13. Merseburger AS, Hennenlotter J, Stenzl A, Beger G, Rinnab L, Kuczyk MA, Kuefer R: Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma. Urol Int 2007;79:41-43.
14. Ng IO, Liang ZD, Cao L, Lee TK: DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res 2000;60:6581-6584.
15. Yuan BZ, Durkin ME, Popescu NC: Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet 2003;140:113-117.
16. Yuan BZ, Zhou X, Durkin ME, Zimonjic DB, Gumundsdottir K, Eyfjord JE, Thorgeirsson SS, Popescu NC: DLC-1 gene inhibits human breast cancer cell grow th and in v ivo tumorigenicity. Oncogene 2003; 22: 445-450.
17. Guan M, Zhou X, Soulitzis N, Spandidos DA, Popescu NC: Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res 2006;12:1412-1419.
18. Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC, Reynolds SH: DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 2004;23: 1405-1411.
19. Sekimata M, Kabuyama Y, Emori Y, Homma Y: Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J Biol Chem 1999; 274:17757-17762.
20. Jaffe AB, Hall A: Rho GTPases in transformation and metastasis. Adv Cancer Res 2002; 84: 57-80.
21. L ozano J, X ing R, Cai Z , Jensen HL, Trempus C, Mark W, Cannon R, Kolesnick R: Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res 2003; 63:4232-4238.
22. Zhou X, Thorgeirsson SS, Popescu NC: Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 2004;23:1308-1313.
23. Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, Urquidi V: The RhoGAP protein DLC-1 functions as a metastasis suppress or in breast cancer cells. Cancer Res 2005;65:6042-6053.
24. Ullmannova V, Popescu NC: Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol 2006; 29:1127-1132.
25. Zhang Q, Ying J, Zhang K, Li H, Ng KM, Zhao Y, He Q, Yang X, Xin D, Liao SK, Tao Q, Jin J: Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. Cancer Lett 2007;249:220-226.
26. Fukata S, Inoue K, Kamada M, Kawada C, Fu ri hata M, Ohtsuk i Y, Shui n T: Levels of an-giogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma. Cancer 2005; 103:931-942.
27. Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H: Expression of metalloprotein-ase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. Urology 2004;63:602-608.